glp 1 agonist in heart failure Impact of GLP-1 receptor agonists on cardiovascular outcomes with preserved ejection fraction (HFpEF): systematic review and meta-analysis | Clinical Research in Cardiology Glucagon-like peptide-1 receptor agonists' impact

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

Ultrasound prediction of fetal macrosomia in pregnancies complicated by diabetes mellitus: a systematic review and meta-analysis

Similarly, weight-related metabolic measurements for blood pressure, triglycerides, HDL (good cholesterol) and HbA1c (a measure for diabetes risk) held steady at their best levels or even improved following the reduction in dose frequency

Nausea, vomiting, diarrhea, and constipation affect a significant percentage of patients, particularly during dose titration